Alcohol consumption deserves special attention
Many of these emerging players are based in China, indicating a potential shift in market dynamics unless major licensing or acquisition deals occur
Moberly SP, Berwick ZC, Kohr M, Svendsen M, Mather KJ, Tune JD: Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow
The Efficacy Ladder: How Every GLP-1 Compares Cross-trial comparisons are imperfect because patient populations, durations, and baseline weights differ
If future research continues to support the heart and kidney benefits seen in current trials, GLP-1 medicines could become part of a broader strategy aimed not only at managing disease but potentially delaying some of its most serious consequences
Often hitting multiple biological pathways is a more effective medication strategy than hitting just one pathway very aggressively